Neogenomics Inc (NASDAQ:NEO)

5.33
Delayed Data
As of Jun 29
 -0.16 / -2.91%
Today’s Change
3.19
Today|||52-Week Range
6.10
+27.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues43.5M59.9M66.5M87.1M
 
 
 
 
 
Cost of Goods Sold22.0M29.4M30.5M42.8M
 
 
 
 
 
Depreciation And Amortization2.1M3.8M4.4M5.6M
 
 
 
 
 
 
Operating ExpensesGross Income19.4M26.7M31.5M38.6M
 
 
 
 
 
General Expenses19.8M25.4M28.3M36.0M
 
 
 
 
 
Research And Development0.002.1M2.2M2.4M
 
 
 
 
Total Operating Expenses43.9M58.7M63.3M84.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-409.0K1.2M3.2M2.6M
 
 
 
 
 
Extraordinary Charge0.000.000.00-361.0K
 
 
Interest Expense On Debt768.0K1.1M989.0K929.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.2M65.0K2.2M1.3M
 
 
 
 
 
Income Taxes0.000.00-152.0K-157.0K
 
 
 
Net Income-1.2M65.0K2.0M1.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.8M45.0M48.3M53.5M
 
 
 
 
 
Shares To Calculate EPS Diluted42.8M48.7M52.8M56.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03$0.00$0.04$0.02
 
 
 
 
EPS Diluted-$0.03$0.00$0.04$0.02
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account